NYSE
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
American Shared Hospital Services leases radiosurgery and radiation therapy equipment to health care providers. As of December 31, 2021, it had 115 operating Gamma Knife units located in the United States, as well as two in South America. The company also operates one PBRT system.
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $17.8M | $17.6M | $19.7M | $21.3M | $28.3M | $28.1M |
| Gross profit | $4.5M | $6.7M | $8.4M | $9.3M | $9.2M | $5.1M |
| Operating income | -$9.5M | $1.4M | $2.4M | $270,000.00 | -$2.8M | -$3.6M |
| Net income | -$7.1M | $194,000.00 | $1.3M | $610,000.00 | $2.2M | -$1.6M |
| Diluted EPS | -$1.14 | $0.03 | $0.21 | $0.10 | $0.33 | -$0.23 |
| Operating cash flow | $9.7M | $6.3M | $7.2M | $5.7M | $167,000.00 | $3.1M |
| Free cash flow | $9.3M | $4.6M | $6.8M | -$555,000.00 | -$7.8M | -$4.5M |
| Gross margin | 25.0% | 38.2% | 42.4% | 43.8% | 32.4% | 18.0% |
| Operating margin | -53.1% | 7.7% | 12.3% | 1.3% | -9.9% | -12.8% |
| Net margin | -39.6% | 1.1% | 6.7% | 2.9% | 7.7% | -5.5% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.1M | $7.0M | $9.1M | $6.1M | $7.1M | $7.2M | $7.7M | $7.1M |
| Gross profit | $2.5M | $1.4M | $3.2M | $942,000.00 | $1.6M | $1.6M | $906,000.00 | $1.3M |
| Operating income | -$1,000.00 | -$889,000.00 | -$1.8M | -$1.3M | -$544,000.00 | -$344,000.00 | -$1.4M | -$924,000.00 |
| Net income | $3.6M | -$207,000.00 | -$1.3M | -$625,000.00 | -$280,000.00 | -$17,000.00 | -$631,000.00 | -$612,000.00 |
| Diluted EPS | $0.55 | -$0.03 | -$0.21 | -$0.10 | -$0.04 | $0.00 | -$0.09 | -$0.09 |
| Operating cash flow | $1.3M | $472,000.00 | $274,000.00 | $2.5M | -$372,000.00 | $1.7M | -$704,000.00 | $2.1M |
| Free cash flow | $70,000.00 | -$407,000.00 | -$4.4M | -$1.5M | -$2.3M | -$2.0M | -$2.7M | $2.1M |
| Gross margin | 35.0% | 19.6% | 35.3% | 15.4% | 23.1% | 22.1% | 11.7% | 18.2% |
| Operating margin | -0.0% | -12.7% | -20.2% | -21.3% | -7.7% | -4.8% | -18.1% | -13.0% |
| Net margin | 51.0% | -3.0% | -14.6% | -10.2% | -4.0% | -0.2% | -8.2% | -8.6% |
Consensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-22 | Stachowiak Raymond C· Executive Chairman | Buy | 586,468 | $2.28 | $1.3M | filing |
| 2026-03-26 | Stachowiak Raymond C· Executive Chairman | Award | 100,000 | $0.00 | $0.00 | filing |
| 2025-06-26 | Stachowiak Raymond C· Executive Chairman | Award | 110,000 | $0.00 | $0.00 | filing |
Latest 3 transactions.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.